Live Breaking News & Updates on Director Mark Coleman
Stay updated with breaking news from Director mark coleman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bellevue Group AG increased its stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 0.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 635,372 shares of the company’s stock after purchasing an additional 3,885 shares during the quarter. Bellevue Group AG owned 1.34% […] ....
Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Free Report) Director Mark Coleman sold 5,249 shares of the firm’s stock in a transaction dated Tuesday, May 28th. The stock was sold at an average price of $75.21, for a total value of $394,777.29. Following the completion of the transaction, the director now directly owns 19,848 shares in […] ....
Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Free Report) have received a consensus rating of “Moderate Buy” from the ten ratings firms that are currently covering the stock, Marketbeat reports. Two research analysts have rated the stock with a hold rating and eight have issued a buy rating on the company. The average 12 […] ....
Profund Advisors LLC Sells 1,681 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Axsome Therapeutics, Inc. (NASDAQ:AXSM) to Post FY2023 Earnings of ($4.19) Per Share, Leerink Partnrs Forecasts themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.